![Sarcoma PDX Models for Drug Testing](https://www.sofpromed.com/wp-content/uploads/2022/07/Sarcoma-PDX-Models-for-Drug-Testing-1080x675.jpg)
![Sarcoma PDX Models for Drug Testing](https://www.sofpromed.com/wp-content/uploads/2022/07/Sarcoma-PDX-Models-for-Drug-Testing-1080x675.jpg)
![Human Sarcoma Cell Lines for Biotech Companies Testing New Drugs](https://www.sofpromed.com/wp-content/uploads/2022/07/Human-Sarcoma-Cell-Lines-for-Biotech-Companies-1080x675.jpg)
by Patricio Ledesma | Jul 10, 2022 | Preclinical
If you are interested in sarcoma patient-derived xenograft (PDX) models for drug testing, please contact us at info@sofpromed.com In vivo sarcoma patient-derived xenograft (PDX) models are essential tools for testing the efficacy and toxicity profile of new compounds...by Patricio Ledesma | Jul 5, 2022 | Preclinical
If you are interested in getting access to patient-derived sarcoma cell lines for drug testing, please contact us at info@sofpromed.com In vitro human-derived sarcoma cell lines are essential tools for conducting sarcoma pharmacogenomic studies that can help to...